UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000029602 |
|---|---|
| Receipt number | R000033822 |
| Scientific Title | Safety and efficacy of pembrolizumab as first-line treatment in elderly patients with non-small cell lung cancer: a pilot study. |
| Date of disclosure of the study information | 2017/10/18 |
| Last modified on | 2022/09/01 10:53:53 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/10/17 22:49:07 | ||
| 2 | Update | 2017/10/19 14:19:10 | Organization Organization Category of Funding Organization Organization1 Tel1 Email1 |
|
| 3 | Update | 2017/11/10 15:15:57 | Public title Acronym |
|
| 4 | Update | 2018/05/30 13:10:56 | Acronym |
|
| 5 | Update | 2018/05/30 13:16:38 | Public title |
|
| 6 | Update | 2021/12/02 12:22:25 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 7 | Update | 2021/12/02 12:25:21 | Recruitment status Date of IRB Last follow-up date |
|
| 8 | Update | 2022/09/01 10:53:53 | Recruitment status |
